Status:
COMPLETED
Alimentation and Diabetes in Lanzarote - ADILAN: a Pilot Trial
Lead Sponsor:
Lund University
Collaborating Sponsors:
Cabildo de Lanzarote
Ayuntamiento de Teguise
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to compare two healthy diets (according to official Spanish guidelines) that have been shown to be effective in the treatment of type 2 diabetes in order to see if one is ...
Detailed Description
There is some uncertainty with respect to the optimal dietary treatment of type 2 diabetes. In addition to energy balance, macronutrient composition, dietary fiber and glycemic load, increasing eviden...
Eligibility Criteria
Inclusion
- Medical diagnosis of type 2 diabetes
- Increased waist circumference (≥80 cm for women and ≥94 cm for men)
- Unaltered medical diabetes treatment since three months before start of study
- Stable weight (varied less than 5%) since three months before start of study
- HbA1c ≥6.0%
Exclusion
- Creatinine \>130 μmol/L
- Change of treatment with betablocker last 3 months
- Change of treatment with thyroid hormone substitution last 3 months
- Treatment with anticoagulant medication
- Oral or injected steroid treatment
- Elevated liver enzymes (AST, ALT, ALP, GPT \> 4 times their respective upper reference value)
- Physical or psychical illness, or changes in personal circumstances that make it impossible for the patient to continue in the study
Key Trial Info
Start Date :
November 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2014
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT01891955
Start Date
November 1 2013
End Date
February 1 2014
Last Update
March 21 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Insular de Lanzarote
Arrecife, Las Palmas, Spain, 35500